These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26384286)

  • 1. Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect.
    Kharbanda C; Alam MS; Hamid H; Javed K; Dhulap A; Bano S; Ali Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4601-5. PubMed ID: 26384286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents.
    Kharbanda C; Alam MS; Hamid H; Javed K; Shafi S; Ali Y; Alam P; Pasha MA; Dhulap A; Bano S; Nazreen S; Haider S
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5298-303. PubMed ID: 25442322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
    Naim MJ; Alam O; Alam MJ; Shaquiquzzaman M; Alam MM; Naidu VGM
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of some new pyrazoline substituted benzenesulfonylureas as potential antiproliferative agents.
    Rathore P; Yaseen S; Ovais S; Bashir R; Yaseen R; Hameed AD; Samim M; Gupta R; Hussain F; Javed K
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1685-91. PubMed ID: 24630557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.
    Nazreen S; Alam MS; Hamid H; Yar MS; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai KK
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3034-42. PubMed ID: 24890090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists.
    El-Zahabi MA; Elbendary ER; Bamanie FH; Radwan MF; Ghareib SA; Eissa IH
    Bioorg Chem; 2019 Oct; 91():103115. PubMed ID: 31310882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
    Nazreen S; Alam MS; Hamid H; Shahar Yar M; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai K
    Arch Pharm (Weinheim); 2015 Jun; 348(6):421-32. PubMed ID: 25900064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
    Nazreen S; Alam MS; Hamid H; Yar MS; Shafi S; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Ali Y; Kharbanda C; Pillai KK
    Eur J Med Chem; 2014 Nov; 87():175-85. PubMed ID: 25255433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
    Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
    Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Piperine Derivatives with Antidiabetic Effect as PPAR-γ Agonists.
    Kharbanda C; Alam MS; Hamid H; Javed K; Bano S; Ali Y; Dhulap A; Alam P; Pasha MA
    Chem Biol Drug Des; 2016 Sep; 88(3):354-62. PubMed ID: 27037532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARgamma-binding patterns.
    Arrault A; Rocchi S; Picard F; Maurois P; Pirotte B; Vamecq J
    Biomed Pharmacother; 2009 Jan; 63(1):56-62. PubMed ID: 18280694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms.
    Liu K; Zhao X; Qi X; Hou DL; Li HB; Gu YH; Xu QL
    Eur J Med Chem; 2021 Jun; 218():113388. PubMed ID: 33784603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, molecular modelling studies and ADME prediction of benzothiazole clubbed oxadiazole-Mannich bases, and evaluation of their anti-diabetic activity through in vivo model.
    Bhutani R; Pathak DP; Kapoor G; Husain A; Kant R; Iqbal MA
    Bioorg Chem; 2018 Apr; 77():6-15. PubMed ID: 29316509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARγ agonists.
    Shukla S; Kumar P; Das N; Moorthy NS; Shrivastava SK; Trivedi P; Srivastava RS
    Med Chem; 2012 Sep; 8(5):834-45. PubMed ID: 22741802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico designing, in vitro and in vivo evaluation of potential PPAR-γ agonists derived from aryl propionic acid scaffold.
    Kharbanda C; Alam MS; Hamid H; Ali Y; Nazreen S; Dhulap A; Alam P; Pasha MAQ
    Bioorg Chem; 2021 Jan; 106():104458. PubMed ID: 33234295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
    Humphries PS; Almaden JV; Barnum SJ; Carlson TJ; Do QQ; Fraser JD; Hess M; Kim YH; Ogilvie KM; Sun S
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6116-9. PubMed ID: 16979341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents.
    Suaifan GA; Shehadeh MB; Darwish RM; Al-Ijel H; Abbate V
    Molecules; 2015 Nov; 20(11):20063-78. PubMed ID: 26561797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
    Humphries PS; Bailey S; Almaden JV; Barnum SJ; Carlson TJ; Christie LC; Do QQ; Fraser JD; Hess M; Kellum J; Kim YH; McClellan GA; Ogilvie KM; Simmons BH; Skalitzky D; Sun S; Wilhite D; Zehnder LR
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6120-3. PubMed ID: 16973358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents.
    Sroor FM; Abbas SY; Basyouni WM; El-Bayouki KAM; El-Mansy MF; Aly HF; Ali SA; Arafa AF; Haroun AA
    Bioorg Chem; 2019 Nov; 92():103290. PubMed ID: 31561109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids.
    Cottineau B; Toto P; Marot C; Pipaud A; Chenault J
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2105-8. PubMed ID: 12127514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.